MedTrace Logo

The Copenhagen Adductor Exercise Trial

NCT03684200 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2018-12-21

No results posted yet for this study

Summary

The purpose of this study is to investigate the efficacy of a 6-week intervention, using the Copenhagen adductor exercise, on adductor muscle strength in sub-elite male footballers. Secondly, it will also examine the effect of a 3-week detraining period, after stopping the Copenhagen adductor exercise, on adductor muscle strength.

The primary outcome measure is eccentric hip adduction strength measured using a handheld dynamometer. Additionally, peak isometric adductor squeeze strength will also be measured using a handheld dynamometer.

The hypothesis is that strength training of the adductor muscles elicited by the Copenhagen adductor exercise will result in enhanced eccentric hip adduction strength.

Conditions

  • Eccentric Hip Adduction Strength

Interventions

OTHER

Copenhagen adductor exercise

The active player is supported on one forearm on the floor and the upper arm is resting along their side. The supporting partner places their hands at the ankle and the knee of the upper leg. The active partner raises their body from the floor and adducts both legs in a three second movement until the body reaches a straight line. The body is then lowered to the ground in a three second movement, the foot of the lower leg touches the ground before performing another repetition.

Sponsors & Collaborators

  • Copenhagen University Hospital, Hvidovre

    collaborator OTHER

  • University of Bath

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
26 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2018-12-04
Completion
2018-12-10

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03684200 on ClinicalTrials.gov